4.2 Article

INTERACTIONS INITATIVES BETWEEN REGULATORY, HEALTH TECHNOLOGY ASSESSMENT AND COVERAGE BODIES, AND INDUSTRY

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0266462312000591

关键词

Decision making; Health; Health policy; Insurance coverage; Regulatory approval; Reimbursement; health insurance; Technology assessment; Biomedical

资金

  1. World Health Organization
  2. Health Technology Assessment International (HTAi)
  3. Centre for Innovation in Regulatory Science (CIRS)
  4. Norwegian Knowledge Center for the Health Services (NOKC)

向作者/读者索取更多资源

There has been an increased focus on the relationship between health technology assessment (HTA) and regulatory assessments and how regulatory, HTA and coverage bodies, and industry can work better together to improve efficiency and alignment of processes. There is increasingly agreement across sectors that improved communication and coordination could contribute to facilitating timely patient access to effective, affordable treatments that offer value to the health system. Discussions on aspects of this relationship are being held in different forums and various forms of coordination and collaboration are being developed or piloted within several jurisdictions. It is therefore both timely and of value to stakeholders to describe and reflect on current initiatives intended to improve interactions between regulatory, HTA and coverage bodies, and industry. Drawing on 2011 meetings of the HTAi Policy Forum and the Center for Innovation in Regulatory Science (CIRS), this study aims to describe and compare initiatives, and point to success factors and challenges that are likely to inform future work and collaboration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据